Literature DB >> 22461645

Applying what we know to accelerate cancer prevention.

Graham A Colditz1, Kathleen Y Wolin, Sarah Gehlert.   

Abstract

More than half of the cancer occurring today is preventable by applying knowledge that we already have. Tobacco, obesity, and physical inactivity are the modifiable causes of cancer that generate the most disease. Cancer burden can be reduced by alterations in individual and population behaviors and by public health efforts as long as these changes are driven by sound scientific knowledge and social commitment to change. The obstacles to these efforts are societal and arise from the organization of institutions, including academia, and in the habits of daily life. To achieve maximal possible cancer prevention, we will need better ways to implement what we know and improved infrastructure that will better incentivize and support transdisciplinary, multilevel research and successful intervention.

Entities:  

Mesh:

Year:  2012        PMID: 22461645      PMCID: PMC3343638          DOI: 10.1126/scitranslmed.3003218

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  64 in total

Review 1.  Science and society: the communications revolution and cancer control.

Authors:  K Viswanath
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

2.  What accounts for the relationship between social class and smoking cessation? Results of a path analysis.

Authors:  Kaori Honjo; Akizumi Tsutsumi; Ichiro Kawachi; Norito Kawakami
Journal:  Soc Sci Med       Date:  2005-07-21       Impact factor: 4.634

Review 3.  Moving forward with breast cancer prevention.

Authors:  Wendy Y Chen; Bernard Rosner; Graham A Colditz
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

4.  Health promotion programs for melanoma prevention: screw or spring?

Authors:  David Hill; Robin Marks
Journal:  Arch Dermatol       Date:  2008-04

Review 5.  Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies.

Authors:  Janet E Dancey; Jose Monzon
Journal:  Future Oncol       Date:  2011-07       Impact factor: 3.404

6.  Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.

Authors:  Johannes A Bogaards; Veerle M H Coupé; Maria Xiridou; Chris J L M Meijer; Jacco Wallinga; Johannes Berkhof
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

7.  Compliance with restrictions on sale of indoor tanning sessions to youth in Minnesota and Massachusetts.

Authors:  Jean L Forster; DeAnn Lazovich; Andrea Hickle; Glorian Sorensen; Marie-France Demierre
Journal:  J Am Acad Dermatol       Date:  2006-08-14       Impact factor: 11.527

8.  Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.

Authors:  Silvana Martino; Jane A Cauley; Elizabeth Barrett-Connor; Trevor J Powles; John Mershon; Damon Disch; Roberta J Secrest; Steven R Cummings
Journal:  J Natl Cancer Inst       Date:  2004-12-01       Impact factor: 13.506

9.  A prospective study of age-specific physical activity and premenopausal breast cancer.

Authors:  Sonia S Maruti; Walter C Willett; Diane Feskanich; Bernard Rosner; Graham A Colditz
Journal:  J Natl Cancer Inst       Date:  2008-05-13       Impact factor: 13.506

10.  Smoking and smoking cessation in relation to mortality in women.

Authors:  Stacey A Kenfield; Meir J Stampfer; Bernard A Rosner; Graham A Colditz
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

View more
  91 in total

1.  Worksite Cancer Prevention Activities in the National Comprehensive Cancer Control Program.

Authors:  Zachary Nahmias; Julie S Townsend; Antonio Neri; Sherri L Stewart
Journal:  J Community Health       Date:  2016-08

2.  Breast cancer prevention knowledge, beliefs, and information sources between non-Hispanic and Hispanic college women for risk reduction focus.

Authors:  Cynthia Kratzke; Anup Amatya; Hugo Vilchis
Journal:  J Community Health       Date:  2015-02

3.  Customer discovery as a tool for moving behavioral interventions into the marketplace: insights from the NCI SPRINT program.

Authors:  April Oh; Anna Gaysynsky; Cheryl L Knott; Nora L Nock; Deborah O Erwin; Cynthia A Vinson
Journal:  Transl Behav Med       Date:  2019-11-25       Impact factor: 3.046

Review 4.  Early Life Exposures and Adult Cancer Risk.

Authors:  Megan A Clarke; Corinne E Joshu
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

Review 5.  Minireview: the year in obesity and cancer.

Authors:  Stephen D Hursting
Journal:  Mol Endocrinol       Date:  2012-10-09

Review 6.  Practicing pathology in the era of big data and personalized medicine.

Authors:  Jiang Gu; Clive R Taylor
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

7.  Microbiota organization is a distinct feature of proximal colorectal cancers.

Authors:  Christine M Dejea; Elizabeth C Wick; Elizabeth M Hechenbleikner; James R White; Jessica L Mark Welch; Blair J Rossetti; Scott N Peterson; Erik C Snesrud; Gary G Borisy; Mark Lazarev; Ellen Stein; Jamuna Vadivelu; April C Roslani; Ausuma A Malik; Jane W Wanyiri; Khean L Goh; Iyadorai Thevambiga; Kai Fu; Fengyi Wan; Nicolas Llosa; Franck Housseau; Katharine Romans; XinQun Wu; Florencia M McAllister; Shaoguang Wu; Bert Vogelstein; Kenneth W Kinzler; Drew M Pardoll; Cynthia L Sears
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 8.  Awareness of Cancer Risk: Variation in Measurement Approaches.

Authors:  Jinan Banna
Journal:  Am J Lifestyle Med       Date:  2017-12-09

Review 9.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

Review 10.  Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane.

Authors:  Li Yang; Dushani L Palliyaguru; Thomas W Kensler
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.